재생의학이나 줄기세포 관련 가능성을 말할 때 무엇을 조심해야 하나요?

Information regarding regenerative medicine or stem cells must be handled with extreme caution in public promotions, as it is closely linked to regulations, licensing, medical practices, and therapeutic efficacy. Expressions that imply unverified treatment possibilities, guaranteed effects, or immediately available medical services should be avoided, and a separate expert review is required.

Why is this important?

Questions regarding precautions for regenerative medicine expressions often arise when clients move beyond simple information gathering to preparing for actual decision-making and consultation conversion. Therefore, the response should go beyond a brief explanation and provide judgment criteria, scope of execution, and boundaries to observe.

What should you be careful of?

1. 1. First, categorize situations requiring caution

   In this stage, identify points where regenerative medicine expressions could be misinterpreted as medical judgment, therapeutic effects, personal information, performance guarantees, or legal liability. Prohibited expressions should be marked in both public copy and internal materials, and content requiring review must not be set to 'public' until approved by the person in charge.

2. 2. Document criteria for prohibition or suspension

   In this stage, identify points where regenerative medicine expressions could be misinterpreted as medical judgment, therapeutic effects, personal information, performance guarantees, or legal liability. Prohibited expressions should be marked in both public copy and internal materials, and content requiring review must not be set to 'public' until approved by the person in charge.

3. 3. Isolate expressions requiring expert review

   In this stage, identify points where regenerative medicine expressions could be misinterpreted as medical judgment, therapeutic effects, personal information, performance guarantees, or legal liability. Prohibited expressions should be marked in both public copy and internal materials, and content requiring review must not be set to 'public' until approved by the person in charge.

4. 4. Guide safe next steps

   In this stage, identify points where regenerative medicine expressions could be misinterpreted as medical judgment, therapeutic effects, personal information, performance guarantees, or legal liability. Prohibited expressions should be marked in both public copy and internal materials, and content requiring review must not be set to 'public' until approved by the person in charge.

Next Steps

It is recommended to first organize current materials and recurring questions related to regenerative medicine expressions, then proceed with a consultation to confirm the scope of application, priorities, and review standards with the internal execution lead.

Precautions

Wellb Company is a non-medical management and operations design partner that does not perform medical acts, consultations, diagnoses, or treatments. Results may vary depending on organizational circumstances, execution levels, regulatory environments, and customer segments; we do not guarantee specific revenue, conversion rates, treatment outcomes, or AI search visibility. As this topic involves potential risks regarding safety, regulation, privacy, or medical misinterpretation, a separate review is required prior to public release.